Group One Trading
ABEO icon

Group One Trading’s Abeona Therapeutics ABEO Stock Holding History

Group One Trading’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$939K Sell
209,607
-114,379
-35% -$572K ﹤0.01% 2788
2025
Q4 		$1.71M Buy
323,986
+275,986
+575% +$1.39M ﹤0.01% 2416
2025
Q3 		$253K Buy
48,000
+9,141
+24% +$58K ﹤0.01% 4417
2025
Q2 		$221K Buy
38,859
+27,470
+241% +$156K ﹤0.01% 4233
2025
Q1 		$54.2K Buy
11,389
+6,489
+132% +$35.3K ﹤0.01% 5098
2024
Q4 		$27.3K Buy
+4,900
New +$30.2K ﹤0.01% 5499
2024
Q3 		– Sell
-6,283
Closed -$32.8K – 6544
2024
Q2 		$26.6K Buy
6,283
+4,526
+258% +$23.1K ﹤0.01% 5015
2024
Q1 		$12.7K Buy
1,757
+991
+129% +$6.28K ﹤0.01% 5725
2023
Q4 		$3.84K Sell
766
-9,234
-92% -$40.6K ﹤0.01% 6612
2023
Q3 		$42.1K Buy
+10,000
New +$37.8K ﹤0.01% 5267
2022
Q4 		– Sell
-3,497
Closed -$11K – 7131
2022
Q3 		$11K Buy
+3,497
New +$14.4K ﹤0.01% 6408
2021
Q2 		– Sell
-335
Closed -$13.7K – 8070
2021
Q1 		$16K Buy
+335
New +$18.5K ﹤0.01% 6841
2020
Q2 		– Sell
-299
Closed -$20.7K – 5720
2020
Q1 		$16K Sell
299
-1,357
-82% -$90.6K ﹤0.01% 4333
2019
Q4 		$135K Buy
1,656
+192
+13% +$13.5K ﹤0.01% 3449
2019
Q3 		$83K Buy
1,464
+11
+0.8% +$824 ﹤0.01% 3680
2019
Q2 		$174K Buy
1,453
+440
+43% +$73.8K ﹤0.01% 2962
2019
Q1 		$186K Buy
1,013
+89
+10% +$15.9K ﹤0.01% 2757
2018
Q4 		$165K Buy
924
+860
+1,344% +$188K ﹤0.01% 2830
2018
Q3 		$21K Buy
+64
New +$22.7K ﹤0.01% 4367
2018
Q2 		– Sell
-71
Closed -$31K – 5026
2018
Q1 		$26K Buy
71
+33
+87% +$12.3K ﹤0.01% 3976
2017
Q4 		$15K Sell
38
-4,198
-99% -$1.74M ﹤0.01% 4243
2017
Q3 		$1.81M Buy
4,236
+3,746
+764% +$1.01M 0.02% 1117
2017
Q2 		$78K Sell
490
-63
-11% -$8.6K ﹤0.01% 3263
2017
Q1 		$69K Sell
553
-123
-18% -$15.9K ﹤0.01% 3210
2016
Q4 		$82K Buy
+676
New +$106K ﹤0.01% 2958
2015
Q4 		– Sell
-215
Closed -$22K – 4682
2015
Q3 		$22K Buy
+215
New +$28.5K ﹤0.01% 3981

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading's ABEO Position: Q1 2026 in Review

Group One Trading reduced its Abeona Therapeutics (ABEO) stake by 35% in Q1 2026, selling an estimated $572K and leaving 209,607 shares worth $939K. The position accounts for ﹤0.01% of the portfolio, ranked #2788.

Group One Trading first reported a position in ABEO in Q3 2015 and has held it in 26 quarters since. The position peaked at $1.81M in Q3 2017. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Group One Trading held 209,607 shares of Abeona Therapeutics worth $939K as of Q1 2026.
  • Group One Trading sold 114,379 Abeona Therapeutics shares in Q1 2026, an estimated $572K.
  • Abeona Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2788 holding.
  • Group One Trading first reported a position in Abeona Therapeutics in Q3 2015 and has held it in 26 quarters since.
  • Group One Trading's Abeona Therapeutics position peaked at $1.81M in Q3 2017.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.